SCHEMBL22381795

SCHEMBL22381795

Nc1ncnn2c([C@@H]3O[C@H](CCO)[C@@H](O)[C@H]3O)ccc12

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ POLRMT O00411 1/20 0.41
▸ DOT1L Q8TEK3 4/20 0.37
▸ HIF1A Q16665 2/20 0.37
▸ STING1 Q86WV6 1/20 0.36
▸ MAP4K4 O95819 1/20 0.35
▸ ADK P55263 1/20 0.34
▸ GAPDH P04406 2/20 0.33
▸ HSD17B10 Q99714 1/20 0.33
▸ DPP4 P27487 1/20 0.33
▸ MEN1 O00255 1/20 0.33
▸ SLC28A1 O00337 1/20 0.33
▸ MAP3K7 O43318 1/20 0.33
▸ SLC28A2 O43868 1/20 0.33
▸ ADORA3 P0DMS8 1/20 0.33
▸ MAPK1 P28482 1/20 0.33
▸ ADORA2A P29274 1/20 0.33
▸ ADORA2B P29275 1/20 0.33
▸ ADORA1 P30542 1/20 0.33
▸ STAT6 P42226 1/20 0.33
▸ PI4KA P42356 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16710417 0.90 HIF1A (0.46) POLRMTDOT1LHIF1AADKGAPDH
SCHEMBL10154369 0.90 HIF1A (0.46) POLRMTDOT1LHIF1AADKGAPDH
SCHEMBL24982322 0.90 HIF1A (0.46) POLRMTDOT1LHIF1AADKGAPDH
SCHEMBL25008855 0.90 HIF1A (0.46) POLRMTDOT1LHIF1AADKGAPDH
SCHEMBL19101808 0.90 HIF1A (0.46) POLRMTDOT1LHIF1AADKGAPDH
SCHEMBL24982409 0.90 HIF1A (0.46) POLRMTDOT1LHIF1AADKGAPDH
SCHEMBL17131346 0.87 POLRMT (0.41) POLRMTDOT1LHIF1ASTING1MAP4K4
SCHEMBL25822093 0.87 POLRMT (0.41) POLRMTDOT1LHIF1ASTING1MAP4K4
SCHEMBL10101548 0.82 POLRMT (0.40) POLRMTDOT1LHIF1ASTING1MAP4K4
SCHEMBL25804330 0.80 POLRMT (0.51) POLRMTADORA1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10759825-B2 Cyclic di-nucleotide compounds as STING agonists MERCK SHARP & DOHME CORP. (US) 2020-09-01 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10759825-B2 Cyclic di-nucleotide compounds as STING agonists STING1, CGAS, IFNAR1 POLRMT 283/4885DOT1L 4213/4885HIF1A 2562/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback